My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidlines Journals & Publications Policy & Advocacy Meetings About IDSA
May 1, 2008
Rift Valley Fever Outbreak in Madagascar

Madagascar has reported an outbreak of Rift Valley Fever, with 418 suspected cases as of mid-April, including 17 deaths (for a case-fatality rate of 4 percent). The cases come from the regions of Alaotra Mangoro, Analamanga, Anosy, Itasy, and Vakinakaratra. According to the Pasteur Institute in Madagascar and the World Health Organization, there have been 59 laboratory-confirmed human cases. Animal cases have also been reported. Control measures have included case management, surveillance, social mobilization, providing medicines, prevention, and strengthening measures to control nosocomial infection. Information on Rift Valley fever—including clinical features, diagnosis, treatment, prevention, and control—is available at http://www.who.int/mediacentre/factsheets/fs207/en/.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


FDA Lowers Vancomycin Breakpoints for Staph Infections
WHO Reports Progress on Dracunculiasis Eradication
IDSA Literature Review - April 2008
Brazil Has Large Dengue Fever Outbreak
Malaria Reported in Bahamas
Polio Eradication Update: Cases Down Overall, But Type 3 Cases Up
Rift Valley Fever Outbreak in Madagascar
Vietnam Reports Cholera Outbreak
Yellow Fever Reported in Liberia, Argentina
Cefixime Available Again in the United States
Drug Approvals, Recalls, Adverse Events Update
In the IDSA Journals
From the President
IDSA Endorses Two Vaccine Financing Bills
IDSA Urges FDA to Dedicate Resources to Antimicrobial Resistance
Members on the Move
Welcome, New IDSA Members!
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.